Buchholz Lab – Medical Systems Biology

About Us

The Buchholz Lab

Systems biology and genome engineering are at the forefront of transforming our healthcare system. The Department of Medical Systems Biology at the University Cancer Center of TU Dresden integrates functional genomics, high-throughput biology and genome editing to transform precision medicine. Join us in shaping the future of healthcare science!

Prof. Dr. Frank Buchholz

Prof. Dr. Frank Buchholz

Frank is passionate about the development and application of functional genomics and genome engineering in biomedical science. He was one of the first scientists to perform genome-scale RNAi screens in human cells, and has pioneered genome surgery as a disruptive new biotechnology. Frank has also been a strong leader in industrial innovation and co-founded several biotechnology companies.

Prof. Dr. Frank Buchholz

Prof. Dr. Frank Buchholz

Frank is passionate about the development and application of functional genomics and genome engineering in biomedical science. He was one of the first scientists to perform genome-scale RNAi screens in human cells, and has pioneered genome surgery as a disruptive new biotechnology. Frank has also been a strong leader in industrial innovation and co-founded several biotechnology companies.

Research

Find out more about our research

Publications

Follow the work of our researchers

Members

Your contact to our research group members

News

Get to know the news of our research group

News

We are co-organising the DG-GT 2025 Annual Meeting!

3. December 2024

We are excited to host the upcoming DG-GT Annual Meeting in Dresden, focusing on the theme "From lab to life – Genome editing towards therapies." We are organizing the meeting together with Deutsche…

Liliya Mukhametzyanova receives Dr Walter Seipp Prize of the Commerzbank Foundation

25. October 2024

Liliya Mukhametzyanova was awarded the Commerzbank Foundation's Dr Walter Seipp Prize for her dissertation on ‘Increasing the utility of evolved site-specific recombinases for genome editing’. With…

SaxoCell enters second phase of funding!

30. August 2024

We are excited to share that SaxoCell has been chosen by the Federal Ministry of Education and Research (BMBF) and an independent expert panel to receive funding for a second phase in the…

Our research group is funded by

At the Buchholz Group, we are passionate about fostering a culture of diversity, equality, and inclusion, because we believe that these values are essential for driving groundbreaking, cutting-edge science!